1hon MSN
A to Z of technology in 2025: A for Agentic AI, B for Blackwell, C for Compute crisis, and more
Twenty-six letters, twelve months, and more plot twists than a season finale. That was 2025 in technology—a year when Chinese ...
TipRanks on MSN
Digital Currency X Technology wins shareholder approval for major capital increase and flexible share consolidation
An update from Digital Currency X Technology ( ($DCX) ) is now available. On December 22, 2025, Digital Currency X Technology Inc. held an ...
The capital injection comes after the Richmond-based company raised about $30 million in the summer amid a US$125-million ...
Some energy experts are challenging N.B. Power’s claim that a proposed billion-dollar power plant in Tantramar is needed to avoid an electricity shortage as early as 2028. Instead, some say, the ...
The institute provides various engineering specialisations, bridge courses, and global exposure programs, focusing on producing future-ready engineers.
The 2024 election has reopened the door for fossil fuels, and B&W's CTO says the company's coal business is thriving as a ...
Kabir Narang is laying the groundwork for a new investment platform slated for 2026 that will focus on "compounding at the ...
Doctors said the technology represents a major advancement in orthopedic care, allowing surgeons to create detailed, 3D ...
The Chosun Ilbo on MSN
Samsung executives indicted for semiconductor technology leak
The Seoul Central District Prosecutors’ Office’s Information Technology Crime Investigation Division (headed by Kim Yoon-yong) announced on the 23rd that it had indicted five individuals, including ...
Castelion secures $350M in Series B funding led by Altimeter and Lightspeed. The defense startup will scale hypersonic production at its new 1,000-acre campus.
6don MSN
Who is Jyoti Bansal, an IIT Delhi graduate on H1-B visa who built a billion-dollar tech empire?
From a small town in Rajasthan, Jyoti Bansal, an IIT Delhi alumnus, has become a billionaire. Arriving on an H1-B visa, he ...
Vyriad announced $25M final tranche of its Series B to support the first-in-human testing of VV169, Vyriad’s in vivo CAR-T ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results